OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF640R conjugate, 0.1mg/mL

Produktübersicht

• Artikelname: OX40 / CD134/ TNFRSF4 (Immuno-Oncology Target)(OX40/3108), CF640R conjugate, 0.1mg/mL
• Artikelnummer: BOT-BNC403108-500
• Hersteller Artikelnummer: BNC403108-500
• Alternativnummer: BOT-BNC403108-500-500UL
• Hersteller: Biotium
• Kategorie: Antikörper
• Applikation: FC, IF, IHC-P
• Konjugation: CF640R

Produktbeschreibung

ThisMAb recognizes a protein of 43 kDa, identified as OX40, which is also known as CD134. OX40 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family. It is expressed on activate

Produkteigenschaften

• Konzentration: 0.1 mg/mL
• Puffer: PBS, 0.1% BSA, 0.05% azide
• Quelle: Animal